Page last updated: 2024-08-21

dehydroepiandrosterone sulfate and Cognitive Decline

dehydroepiandrosterone sulfate has been researched along with Cognitive Decline in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (50.00)24.3611
2020's3 (50.00)2.80

Authors

AuthorsStudies
Chan, A; Lau, AJ; Parajuli, R; Tan, CJ; Toh, YL; Yap, NY1
Clark, C; Kirschbaum, C; Ouanes, S; Popp, J; Rabl, M1
Elpers, AL; Steptoe, A1
Bansal, S; Chan, A; Lau, AJ; Shariq Mujtaba, J; Shwe, M; Toh, YL; Yeo, A1
Chan, M; Chong, MS; Lim, WS; Tay, L; Ye, RJ1
Banerjee, P; Brinkman, TM; Chemaitilly, W; Cheung, YT; Hudson, MM; Krull, KR; Liu, W; Mulrooney, DA; Pui, CH; Robison, LL; Srivastava, D1

Other Studies

6 other study(ies) available for dehydroepiandrosterone sulfate and Cognitive Decline

ArticleYear
Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
    Scientific reports, 2022, 10-03, Volume: 12, Issue:1

    Topics: Breast Neoplasms; Cognitive Dysfunction; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Estradiol; Female; Humans; Sulfates

2022
Persisting neuropsychiatric symptoms, Alzheimer's disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate.
    Alzheimer's research & therapy, 2022, 12-19, Volume: 14, Issue:1

    Topics: Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Dehydroepiandrosterone Sulfate; Dementia; Humans; Hydrocortisone; Hypothalamo-Hypophyseal System; Neuropsychological Tests; Pituitary-Adrenal System; Prospective Studies

2022
Associations between dehydroepiandrosterone sulphate (DHEAS) and cognitive function in 5,061 older men and women in the English Longitudinal Study of Ageing.
    Psychoneuroendocrinology, 2020, Volume: 117

    Topics: Aged; Aging; Cognition; Cognitive Aging; Cognitive Dysfunction; Cross-Sectional Studies; Dehydroepiandrosterone Sulfate; Female; Humans; Longitudinal Studies; Male; Middle Aged; Sex Factors

2020
Prechemotherapy Levels of Plasma Dehydroepiandrosterone and Its Sulfated Form as Predictors of Cancer-Related Cognitive Impairment in Patients with Breast Cancer Receiving Chemotherapy.
    Pharmacotherapy, 2019, Volume: 39, Issue:5

    Topics: Antineoplastic Agents; Breast Neoplasms; Cognitive Dysfunction; Cohort Studies; Dehydroepiandrosterone; Dehydroepiandrosterone Sulfate; Female; Humans; Logistic Models; Middle Aged; Multivariate Analysis; Neoplasm Staging; Predictive Value of Tests; Prospective Studies; Singapore

2019
The Independent Role of Inflammation in Physical Frailty among Older Adults with Mild Cognitive Impairment and Mild-to-Moderate Alzheimer's Disease.
    The journal of nutrition, health & aging, 2016, Volume: 20, Issue:3

    Topics: Aged; Alzheimer Disease; Biomarkers; Cognitive Dysfunction; Cohort Studies; Dehydroepiandrosterone Sulfate; Female; Frail Elderly; Humans; Inflammation; Insulin-Like Growth Factor I; Interleukin-6; Male; Multivariate Analysis; Prospective Studies; Tumor Necrosis Factor-alpha

2016
Association between dehydroepiandrosterone-sulfate and attention in long-term survivors of childhood acute lymphoblastic leukemia treated with only chemotherapy.
    Psychoneuroendocrinology, 2017, Volume: 76

    Topics: Adolescent; Adrenal Insufficiency; Adult; Antineoplastic Agents; Attention; Child; Cognitive Dysfunction; Dehydroepiandrosterone Sulfate; Female; Follow-Up Studies; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sex Factors; Survivors; Young Adult

2017